Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: VoodooFL who wrote (4821)	12/8/1998 9:53:00 AM
From: Dixie7777	Respond to of 5736

To implement its marketing efforts, the Company has recently opened a medical marketing, sales and distribution support division in Connecticut and hired Vice President Sheila Kempf and other qualified sales, marketing and inservicing staff there. While Chromatics remains in ongoing negotiations to reach a definitive agreement and continues to move toward the completion of required due diligence with potential global distributors, the Company anticipates shipping the newly-manufactured monitors from that office in order to accommodate the interest already generated at the conferences for the TLc-BiliTest(TM). Both an electronically powered model of the device and a lightweight hand-held battery operated monitor will be manufactured under FDA QSR as well as ISO 9000 manufacturing regulatory requirements. The Company's new contract manufacturer is an ISO 9001-certified facility. The System includes a proprietary calibration standard for each non-invasive measurement taken on an infant while being measured for hyperbilirubinemia.

To: VoodooFL who wrote (4821)	12/8/1998 12:55:00 PM
From: Peter V	Read Replies (1) \| Respond to of 5736

The reason the lack of disclosure of the manufacturer is noteworthy is because it is one of a string of nebulous announcements by CCSI. It makes it impossible to independently verify the announcement, the amount of devices slated for manufacture, or any of the pertinent details that allow independent analysis of the potential for CCSI to see any revenue. Maybe there really is some sort of valid competitive reason that CCSI refuses to disclose the manufacturer, but it continues to look like CCSI management is hiding the ball, as they have done for well over a year since they received FDA approval for the device.